GI
BEAM icon

GAMMA Investing’s Beam Therapeutics BEAM Stock Holding History

GAMMA Investing’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.5K Sell
975
-144
-13% -$4.35K ﹤0.01% 2555
2026
Q1 		$26.7K Buy
1,119
+533
+91% +$14.8K ﹤0.01% 2566
2025
Q4 		$16.2K Buy
586
+325
+125% +$8.29K ﹤0.01% 2725
2025
Q3 		$6.33K Sell
261
-434
-62% -$8.63K ﹤0.01% 3083
2025
Q2 		$11.8K Sell
695
-1,209
-63% -$21.1K ﹤0.01% 2727
2025
Q1 		$37.2K Sell
1,904
-3,818
-67% -$100K ﹤0.01% 2002
2024
Q4 		$142K Buy
5,722
+1,102
+24% +$28.1K 0.01% 883
2024
Q3 		$113K Buy
4,620
+544
+13% +$14.1K 0.01% 916
2024
Q2 		$95.5K Buy
4,076
+3,691
+959% +$90.7K 0.01% 801
2024
Q1 		$12.7K Buy
385
+153
+66% +$4.77K ﹤0.01% 1923
2023
Q4 		$5.66K Buy
+232
New +$5.76K ﹤0.01% 2179

Other funds holding BEAM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
BFS
Beacon Financial Strategies Raleigh, North Carolina $201M AUM 19.14% 1-Year Est. Return
TWM
Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return

GAMMA Investing's BEAM Position: Q2 2026 in Review

GAMMA Investing reduced its Beam Therapeutics (BEAM) stake by 13% in Q2 2026, selling an estimated $4.35K and leaving 975 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

GAMMA Investing first reported a position in BEAM in Q4 2023 and has held it in 11 quarters since. The position peaked at $142K in Q4 2024. 14 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • GAMMA Investing held 975 shares of Beam Therapeutics worth $33.5K as of Q2 2026.
  • GAMMA Investing sold 144 Beam Therapeutics shares in Q2 2026, an estimated $4.35K.
  • Beam Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2555 holding.
  • GAMMA Investing first reported a position in Beam Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Beam Therapeutics position peaked at $142K in Q4 2024.
  • 14 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.